News
Home/ News
(Filtering posts by category: Patents) - Remove filter
In a ruling that could reshape India’s heart drug market, the Indian Patent Office has revoked Novartis’ patent for its blockbuster therapy Vymada (sold internationally as Entresto). The decision, issued on September 12, found that Novartis’ claims lacked novelty, inventive step, and sufficient proof of enhanced efficacy.
Australia remains one of the few jurisdictions that requires a patent applicant to disclose the “best method” of carrying out an invention. This requirement is strictly enforced — and in recent years, it has become a powerful ground for revoking patents, particularly in the context of divisional applications.
Indonesia isn’t just our closest neighbour — it’s ASEAN’s largest economy, home to more than 270 million people, and one of the fastest-transforming markets in the world. Indonesia’s rise offers an unprecedented opportunity for Australian businesses.
Electric vehicles (EVs) are becoming one of the fastest-growing areas for intellectual property filings. For businesses innovating in EVs, batteries, or related technologies, protecting your IP is essential to compete in this rapidly growing market.
Many Australians may not realise that pharmaceutical products — including packaged medicines, wound care items, and blood products — are among Australia’s top exports to the United States. In 2024, these exports reached around US$1.35 billion. So what’s the issue here? It’s not just about trade volumes — it’s about how patents and regulatory systems impact market access, costs, and competition.
When we think about intellectual property in the fashion world, we often think of logos, brand names, or design rights protecting the look of a product. But sometimes, patents—usually associated with inventions and technology—step onto the runway too.
The Intellectual Property Office of Singapore (IPOS) has rolled out two new fast-track options for patents and trade marks: SG Patents Fast and SG Trade Marks Fast, designed to help businesses get their IP rights granted more quickly—cutting down on waiting time and helping you move faster in the market.
When you open Google Maps to find a coffee shop, plan your drive, or check traffic, you probably don’t think about patents. But patents are a big part of why Google Maps is the leader in navigation technology — and why it’s so hard for competitors to catch up.
In a recent decision that has implications for pharmaceutical patent strategy in Australia, the Federal Court has both clarified and complicated the rules around patent term extensions (PTEs).
